Chiquita Brooks-LaSure, Centers for Medicare and Medicaid Services administrator (AP Photo/Evan Vucci)
June 1, 2023 02:05 PM EDTUpdated 03:00 PM
Pharma

CMS makes it of­fi­cial: Cov­er­age for new Alzheimer's drugs once full ap­provals ar­rive

Zachary Brennan

Senior Editor

As Con­gres­sion­al and ad­vo­ca­cy group pres­sure has been heat­ed, the Cen­ters for Medicare and Med­ic­aid Ser­vices reaf­firmed to­day that if amy­loid-tar­get­ed drugs to slow the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times